|
EGUSIN SLH® and EGUSIN 250® by Centaur Animal Health
EGUSIN SLH® for horses exhibiting gut disturbances and EGUSIN 250® to maintain a healthy gut -by the decicated team at Centaur Animal Health About Centaur Animal HealthSince it was founded in 1986, Centaur Animal Health business focus has been concentrated in adaptations of proven new technology -- with special emphasis in biotechnology -- converting successes from the human healthcare market to help similar problems in the animal health markets. Centaur’s first products were concentrated in the equine market, and focused on diagnostic technologies that were representative of ‘breakthrough innovations’. One such product is the Equine Infectious Anemia (EIA) diagnostic that was adapted from the human Aids test and for which a patent was granted in 1995.Centaur Animal Health and United Agriculture and Veterinary Products, Inc. (Unavet) were two separate Kansas City based animal health businesses that have been operational since the mid 1980’s. Both companies had been engaged in sales activity in separate but complimentary segments of the animal health market. The merging of the two existing companies in 2001 provided efficiencies and growth opportunities available that would not have been available to either company individually.
What Customers Say
|
Per Centaur Animal Health: EGUSIN SLH® is positioned for horses exhibiting gut disturbances; EGUSIN 250® is positioned for maintaining a healthy gut. Both products carry the EGUSIN ® trademark.
EGUSIN is made by Centaur Animal Health, founded in 1986 with a focus on adapting biotechnology breakthroughs from the human-healthcare market to animal-health applications. Their first equine product was a diagnostic adapted from the human AIDS test for Equine Infectious Anemia (EIA), patented in 1995.
Centaur Animal Health was originally a Kansas City-based animal-health business, dating back to the mid-1980s. In 2001 it merged with United Agriculture and Veterinary Products, Inc. (Unavet), a complementary Kansas City company, to expand its reach in the animal-health market.
Their stated approach is to convert proven successes from the human-healthcare market to similar problems in animal health. The company describes this as their special emphasis — applying breakthrough innovations cross-species rather than starting from zero.
Source materials position the two products differently: EGUSIN 250® is for maintaining a healthy gut (suggesting daily use), while EGUSIN SLH® is for horses already exhibiting gut disturbances. The decision between the two is between you and your veterinarian.
Explore more from the InfoHorse.com directory